Press Release
February 26, 2009 – Houston, TX – LC Sciences has announced the availability of a custom target enrichment service for next-generation sequencing applications.  LC Sciences now provides a service for Target-Specific Selection of a defined genomic region (such as Mbp region at a specific location, suspected cancer regions, SNP regions, regions for genomic comparisons) or […]
Read More
Press Release
Sept 17, 2008 – Houston, TX – Non-coding (ncRNAs) are a large class of RNAs which do not encode proteins but possess regulatory functions at the level of translation in cells of various species.  There are an increasing amount of data suggesting that there are likely many more ncRNAs that exist, yet to be discovered.  […]
Read More
Press Release
May 6, 2008 – Houston, TX – LC Sciences announced today that it has entered into a strategic marketing alliance with DNAVision to increase accessibility to its custom microRNA profiling service and enhance both its customer and technical service to researchers in Europe.  LC Sciences’ microRNA profiling service is powered by µParaflo® microfluidic technology and […]
Read More
Press Release
August 9, 2007 – Houston, TX – Taking advantage of its flexible µParaflo™ Chip Technology, Houston based LC Sciences today announced immediate availability of probe content miRBase 10.0 for their microRNA (miRNA) microarray customers. This announcement comes less than a week after Sanger Institute’s update of their sequence database for known miRNAs (miRBase)1 to version […]
Read More
Press Release
May 9, 2006 – Houston, TX – LC Sciences announced today that the probe content of its line of standard and custom micoRNA microarrays used in their comprehensive expression profiling service would keep pace with the latest version (Release 8.1) of the Sanger miRBase sequence database and that microarrays containing the new sequences are already […]
Read More
Massive Parallel Synthesis The scientists and engineers at our technology partner, Atactic Technologies, have developed platform technologies that encompass a new class of microfluidic µParaflo® reaction devices, an advanced digital light synthesizer apparatus, and picoliter scale biochemical processes.  The functionalized µParaflo® chips are particularly suited for applications where small sample consumption, contamination-free, and performance-reproducibility are […]
Read More
The regulatory effects microRNA of are widespread and microRNAs have recently been implicated in various diseases of the blood, stem cells, brain, and other tissues. MicroRNAs are expressed in the blood A study involving sickle cell diseases revealed that there is significant microRNA expression in red blood cells[1] and another showed that microRNAs are highly […]
Read More
This month, researchers at the Department of Biological Sciences at the University of Lethbridge published the latest in a series of papers describing characterization of breast cancer using microRNA expression profiling and epigenomic and proteomic measurements in rat model. “Estrogen-Induced Rat Breast Carcinogenesis is Characterized by Alterations in DNA Methylation, Histone Modifications and Aberrant MicroRNA […]
Read More
Heart disease and cancer represent the number one and number two killer diseases in developed countries. Identifying biomarkers to detect these and other diseases at early stages remains an important research goal and researchers are scrambling for ways to identify contributing factors to the pathogenesis of diseased cells in the body.  In recent years, research […]
Read More
Plasma
Molecular Diagnostics / Biomarkers – Identification of specific miRNAs or miRNA expression based signatures that can act as biomarkers for various diseases/pathologies. Make accurate and detailed clinical diagnosis Determine prognosis and predict treatment efficacy Monitor and assess the health effects of environmental and other toxicants Drug Discovery / Therapeutics – Identification of miRNAs that play […]
Read More